Results 191 to 200 of about 9,772 (228)

Pharmacodynamics of triptans

2001
Abstract The triptans belong to a class of drugs known as 5-HT1B/1D, previously 5-HT1-like or 5-HT1D receptor agonists’. The frst of this class, sumatriptan, is a signifcant advance in migraine therapy. Several new triptans are on the market (zolmitriptan, rizatriptan, and naratriptan), while others (eletriptan, almotriptan, frovatriptan,
openaire   +1 more source

Triptans for Migraine Prodrome

Headache: The Journal of Head and Face Pain, 2002
Randolph W, Evans, Lisa K, Mannix
openaire   +2 more sources

Triptans and migraine

The Lancet, 2000
openaire   +2 more sources

The Triptans

2007
ANTHONY J. TOMASSONI, CARL A. GERMANN
openaire   +1 more source

Triptans

2006
openaire   +2 more sources

Triptans (Serotonin, 5-HT 1B/1D Agonists) in Migraine: Detailed Results and Methods of A Meta-Analysis of 53 Trials

Cephalalgia, 2002
Michel D Ferrari, Peter J Goadsby, Rb Lipton   +2 more
exaly  

Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials

Lancet, The, 2001
Michel D Ferrari, Richard B Lipton, Peter J Goadsby   +2 more
exaly  

Triptans and CNS Side-Effects

Cephalalgia, 2004
Dw Dodick, Vicente Martin
exaly  

Triptans and Serotonin Syndrome*

Headache: The Journal of Head and Face Pain, 2012
Andrew, Fine, Eric, Bastings
openaire   +2 more sources

The new triptans.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique, 2001
In the past 10 years, new compounds have been developed for the acute treatment of migraine. Studies of a group of compounds called the triptans are summarized. The triptans are derived from the serotonin molecule and act on the 5-hydroxytryptamine 1B/1D receptors.
openaire   +1 more source